Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ivan Tijanić"'
Publikováno v:
São Paulo Medical Journal (2022)
Abstract BACKGROUND: In this era of target therapies, novel data on the correlation between response endpoints and survival outcomes in multiple myeloma have arisen. OBJECTIVE: To determine the impact of quality of response on clinical outcomes, usin
Externí odkaz:
https://doaj.org/article/965033da2be94b8d8b4af8417b1b67da
Publikováno v:
Acta stomatologica Naissi. 36:2007-2010
Introduction: Despite substantial advances in the treatment of Hemophilia A with the use of concentrated factor VIII preparations during recent decades, bleeding episodes still occur from time to time. The development of inhibitors significantly redu
Publikováno v:
Romanian Journal of Laboratory Medicine, Vol 23, Iss 3, Pp 275-283 (2015)
Introduction. In recent years, determination of soluble transferrin receptor levels has been emerging as a test that can reliably indicate iron deficiency in various states, and that is non-invasive and easy to use. The aim of this study was: to dete
Autor:
Ivan Tijanić, Lana Macukanovic-Golubovic, Miodrag Vučić, Milos Tijanic, Goran Marjanovic, Nikola Buric
Publikováno v:
Acta stomatologica Naissi. 31:1486-1492
Hemophilia A is an inherited disease characterized by deficiency of coagulation factor VIII and bleeding tendency. It is transmitted through the X chromosome. Hemophilia A is characterized by excessive bleeding in various tissues of the body, includi
Publikováno v:
Clinical lymphoma, myelomaleukemia. 17(10)
Previous studies have indicated that the effect of age at the diagnosis of chronic myeloid leukemia (CML) is minimized in patients treated with imatinib. The treatment response and survival rates were similar for younger and elderly patients. The aim
Publikováno v:
Open Medicine, Vol 6, Iss 2, Pp 181-184 (2011)
The preparation of thrombocyte concentrates with filtration before storage (in-line) makes it possible to avoid the presence of mononuclear cells in the concentrate and proinflammatory cytokines. Therefore, this filtration may result with decreased a
Autor:
Graham P. Collins, Toby A. Eyre, Debora Schmitz-Rohmer, William Townsend, Rakesh Popat, Lisa Giulino-Roth, Paul A. Fields, Fatime Krasniqi, Carole Soussain, Anastasios Stathis, Nebojsa Andjelkovic, David Cunningham, Danijela Mandic, Sinisa Radulovic, Ivan Tijanic, Netanel A. Horowitz, Sabira Kurtovic, Elisabeth Schorb, Christian Schmidt, Saša Dimitrijević, Martin Dreyling
Publikováno v:
HemaSphere, Vol 5, Iss 11, p e656 (2021)
Bimiralisib is an orally bioavailable pan-phosphatidylinositol 3-kinase and mammalian target of rapamycin inhibitor which has shown activity against lymphoma in preclinical models. This phase I/II study evaluated the response rate to bimiralisib at 2
Externí odkaz:
https://doaj.org/article/8e18548fde2a404c9bbf77be27391d61
Autor:
Ivan, Tijanić, Miodrag, Vučić, Nenad, Govedarović, Miloš, Tijanić, Lana, Mačukanović-Golubović
Publikováno v:
Acta Stomatologica Naissi; 2009, Vol. 25 Issue 59, p883-888, 6p
Autor:
Ivan, Tijanić, Miodrag, Vučić, Nenad, Govedarović, Miloš, Tijanić, Lana, Mačukanović-Golubović
Publikováno v:
Acta Stomatologica Naissi; 2009, Vol. 25 Issue 59, p883-887, 5p